ArticleSurgical case reports2022

Long-term management of recurrent papillary thyroid carcinoma treated with lenvatinib for over 5 years: a case report.

Tsuneo Imai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.